Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 218-463-4 | CAS number: 2156-97-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2008-01-24 to 2008-03-14
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study according to OECD TG No. 474 and in compliance with GLP Regulations.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 21 Jul 1997
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Reaction mass of (D)-2-Propylheptyl acrylate and (L)-2-Propylheptyl acrylate
- EC Number:
- 604-669-5
- Cas Number:
- 149021-58-9
- Molecular formula:
- C13 H24 O2
- IUPAC Name:
- Reaction mass of (D)-2-Propylheptyl acrylate and (L)-2-Propylheptyl acrylate
- Test material form:
- other: liquid
- Details on test material:
- - Name of test material: 2-Propylheptylacrylat rein
-Test substance number: 07/0846-1
- Analytical purity: 98.5 area-%
- Isomers composition: about 87 % 2 Propylheptylacrylate and 10 % 4-methyl-2-propylhexylacrylate
- Analytical report no.: 07L00384
- Lot/batch No.: B4112/13 - 03122007
- Expiration date of the lot/batch: 2008-12-03
- pH-value: Ca. 5.5 (undiluted test substance)
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Mice / Crl:NMRI from Charles River Laboratories Germany GmbH.
- Age at study initiation: 5 – 8 weeks
- Weight at study initiation: 29.3 g (mean bw)
- Assigned to test groups randomly: The animals were assigned to the test groups according to a randomization plan prepared with an appropriate computer program.
- Housing: Makrolon cages, type M I; single housing
- Diet: Standardized pelleted feed (Maus/Ratte Haltung "GLP", Provimi Kliba SA, Kaiseraugst, Switzerland)
- Water: Drinking water from bottles was available ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 20-24°C
- Humidity: 30-70%
- Photoperiod (hrs dark / hrs light): 12 hours light from 6.00 - 18.00 hours; 12 hours darkness from 18.00 - 6.00 hours
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Justification for choice of solvent/vehicle: Due to the limited solubility of the test substance in water, corn oil was selected as the vehicle, which had been demonstrated to be suitable in the in vivo micronucleus test and for which historical data are available.
- Concentration of test material in vehicle: 500 mg/kg body weight or 10 mL/kg body weight of a test substance solution with a concentration of 50 mg/mL.
1000 mg/kg body weight or 10 mL/kg body weight of a test substance solution with a concentration of 100 mg/mL.
2000 mg/kg body weight or 10 mL/kg body weight of a test substance solution with a concentration of 200 mg/mL.
- Amount of vehicle (if gavage or dermal): 10 mL.
-Stability: The stability of the test substance at room temperature in the vehicle corn oil was determined analytically. - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: To achieve a solution of the test substance in the vehicle, the test substance preparation was
shaken thoroughly.
The animals were treated once orally (gavage) with a volume of 10 mL/kg body weight of the test substance, the vehicle and the positive control substances - Duration of treatment / exposure:
- The animals were sacrificed 24 hours (all test substance concentrations, vehicle, both positive controls) and 48 hours
(highest test substance concentration, vehicle) after the treatment, respectively. - Frequency of treatment:
- The animals were treated once.
- Post exposure period:
- None.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
500, 1000, and 2000 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- 5 males per dose
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- -Cyclophosphamide, Vincristine sulfate
- Justification for choice of positive control(s): well-established reference clastogens and aneugens
- Route of administration: oral, gavage (Cyclophosphamide), peritoneal (Vincristine sulfate)
- Doses / concentrations: Cyclophosphamide: 20 mg/kg body weight, Vincristine sulfate: 0.15 mg/kg body weight
Examinations
- Tissues and cell types examined:
- Bone marrow of femora (normochromatic and polychromatic erythrocytes)
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
In a pretest for the determination of the acute oral toxicity, at 2 000 mg/kg body weight recommended as the highest dose according to the OECD Guideline all animals (male and female) survived. The only clinical sign observed was hunched posture. However, there were no distinct differences in the symptoms between males and females. Thus, only male animals were used for the cytogenetic investigations. Therefore, a dose of 2000 mg/kg body weight was selected as the highest dose in the present cytogenetic study. 1000 mg/kg and 500 mg/kg body weight were administered as further doses.
DETAILS OF SLIDE PREPARATION:
The two femora of the animals sacrificed by cervical dislocation were prepared by dissection and removing all soft tissues.
- After cutting off the epiphyses, the bone marrow was flushed out of the diaphysis into a centrifuge tube using a cannula filled with fetal calf serum (FCS) which was preheated up to 37°C (about 2 mL/femur).
- The suspension was mixed thoroughly with a pipette and centrifuged at 300 x g for 5 minutes. The supernatant was removed and the precipitate was resuspended in about 50 μL fresh FCS.
- One drop of this suspension was dropped onto clean microscopic slides, using a Pasteur pipette. Smears were prepared using slides with ground edges. The preparations were dried in the air and subsequently stained.
The slides were stained with eosin and methylene blue (modified May-Grünwald solution or Wrights solution) for about 5 minutes.
- After briefly rinsing in purified water, the preparations were soaked in purified water for about 2 - 3 minutes.
- Subsequently, the slides were stained with Giemsa solution (15 mL Giemsa plus 185 mL purified water) for about 15 minutes.
- After rinsing twice in purified water and clarifying in xylene, the preparations were mounted in Corbit-Balsam. - Evaluation criteria:
- In general, 2 000 polychromatic erythrocytes (PCE) were evaluated for the occurrence of micronuclei from each animal of every test group, so in total 10 000 PCEs were scored per test group. The normochromatic erythrocytes (= normocytes / NCE) were also scored.
Acceptance criteria:
-The quality of the slides must allow the evaluation of a sufficient number of analyzable cells; i. e. ≥ 2 000 PCEs per animal and a clear differentiation between PCEs and NCEs.
The ratio of PCEs/NCEs in the concurrent vehicle control animals has to be within the normal range for the animal strain selected.
The number of cells containing micronuclei in vehicle control animals has to be within the range of the historical vehicle control data both for PCEs and for NCEs.
The two positive control substances have to induce a distinct increase in the number of PCEs containing small and/or large micronuclei within the range of the historical positive control data or above.
Assessment criteria
A finding is considered positive if the following criteria are met:
-Statistically significant and dose-related increase in the number of PCEs containing micronuclei.
The number of PCEs containing micronuclei has to exceed both the concurrent vehicle control value and the range of the historical vehicle control data.
A test substance is considered negative if the following criteria are met:
The number of cells containing micronuclei in the dose groups is not statistically significant increased above the concurrent vehicle control value and is within the range of the historical vehicle control data. - Statistics:
- The statistical evaluation of the data was carried out using the program system MUKERN (BASF SE). The asymptotic U test according to MANN-WHITNEY (modified rank test according to WILCOXON) was carried out to clarify the question whether there are statistically significant differences between the untreated control group and the treated dose groups with regard to the micronucleus rate in polychromatic erythrocytes. The relative frequencies of cells containing micronuclei of each animal were used as a criterion for the rank determination for the U test. Statistical significances were identified as follows:
* p ≤ 0.05
** p ≤ 0.01
However, both biological relevance and statistical significance were considered together.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- weak clinical signs of toxicity (hunched posture)
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- The single oral administration of the vehicle corn oil in a volume of 10 mL/kg bw led to 1.2 ‰ polychromatic erythrocytes containing micronuclei after the 24-hour sacrifice interval or to 1.3‰ after the 48-hour sacrifice interval, respectively.
After the single administration of the highest dose of 2000 mg/kg body weight, 1.3‰ polychromatic erythrocytes containing micronuclei were found after 24 hours and 3.0‰ after 48 hours.
In the two lower dose groups, rates of micronuclei of about 1.9‰ (1000 mg/kg bw group) and 2.4‰ (500 mg/kg bw group) were detected after a sacrifice interval of 24 hours in each case.
The positive control substance for clastogenicity, cyclophosphamide, led to a statistically significant increase (14.4‰) in the number of polychromatic erythrocytes containing exclusively small micronuclei, as expected.
Vincristine sulfate, a spindle poison, produced a 66.4‰ increase in micronuclei in polychromatic erythrocytes. A significant portion increase, 14.6‰ was attributable to large micronuclei.
The number of normochromatic erythrocytes containing micronuclei did not differ to any appreciable extent in the vehicle control group or in the various dose groups at any of the sacrifice intervals.
No inhibition of erythropoiesis was observed.
Clinical signs:
All animals in all dose groups showed a hunched posture up to 2 and 4 h after treatment.
Any other information on results incl. tables
Number of total PCE and total NCE and number of PCE/NCE with micronuclei:
|
Interval 24 h |
Interval 48 h |
||||||
|
Total No of |
MN (o/oo) in |
Total No of |
MN (o/oo) in |
||||
|
PCE |
NCE |
PCE |
NCE |
PCE |
NCE |
PCE |
NCE |
Vehicle corn oil |
10000 |
4338 |
1.2 |
0.7 |
10000 |
4494 |
1.3 |
0.2 |
500 mg/kg |
10000 |
4188 |
2.4 |
0.5 |
|
|
|
|
1000 mg/kg |
10000 |
5239 |
1.9 |
1.3 |
|
|
|
|
2000 mg/kg |
10000 |
4103 |
1.3 |
0.2 |
10000 |
5109 |
3.0* |
1.2 |
CPP 20 mg/kg |
10000 |
2835 |
14.4** |
1.8 |
|
|
|
|
VCR 0.15 mg/kg |
10000 |
5687 |
66.4** |
1.1 |
|
|
|
|
Proportion of small and large micronuclei per total of 10000 PCEs:
|
Interval 24 h |
Interval 48 h |
||||||
|
Total No of |
cells (o/oo) with |
Total No of |
cells (o/oo) with |
||||
|
PCE |
|
MN d<D/4 |
MN d>=D/4 |
PCE |
|
MN d<D/4 |
MN d>=D/4 |
Vehicle corn oil |
10000 |
|
1.1 |
0.1 |
10000 |
|
1.3 |
0 |
500 mg/kg |
10000 |
|
2.4 |
0 |
|
|
|
|
1000 mg/kg |
10000 |
|
1.9 |
0 |
|
|
|
|
2000 mg/kg |
10000 |
|
1.3 |
0 |
10000 |
|
2.9* |
0.1 |
CPP 20 mg/kg |
10000 |
|
14.4** |
0 |
|
|
|
|
VCR 0.15 mg/kg |
10000 |
|
51.8** |
14.6** |
|
|
|
|
*: p<=0.05
**: p<=0.01
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.